Rethix Bridge LLC

Rethix Molecular Diagnostics Lab is a full-fledged molecular diagnostics laboratory born from the world’s first liaison research organization bridging ethics with research. We have evolved to offer state-of-the-art genetic and molecular testing while continuing to support clinical research and innovation. Our name – derived from “ethics” – reflects an unwavering commitment to regulatory compliance and integrity in every project. Comprehensive Services in Advanced Diagnostics: Our diagnostic portfolio encompasses over 60 specialized tests across key areas: - Prenatal & Reproductive Genetics: Rapid aneuploidy detection with QF-PCR and other prenatal screenings. - Oncology & Hereditary Disease: Molecular assays like BCR-ABL1 real-time PCR for leukemia monitoring and BRCA1/2 gene analysis by NGS for cancer risk. - Immunogenetics & Transplant: High-resolution HLA typing and related compatibility testing. - Genomic Medicine: Cutting-edge microarray analysis and whole-exome sequencing (ORION) for comprehensive genetic insights. Commitment to Quality, Compliance, and Innovation: Rethix partners with healthcare providers, research institutions, and investors to bring precision, innovation, and accessibility to healthcare. Our laboratory is COFEPRIS-certified in Mexico and adheres to the highest international quality standards, instilling confidence in every result. We have built a world-class facility that sets new benchmarks in compliance, validation, and operational excellence – delivering accurate, actionable results with turnaround times that empower timely decision-making. Future-focused and trustworthy, Rethix remains dedicated to advancing medical knowledge and patient care. By uniting rigorous ethical standards with cutting-edge technology, we are shaping the future of diagnostics and clinical research – making high-quality, personalized medicine more precise and accessible for all.